Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: REJUVENATE BIO INC.
Awarding agency: Department of Defense / Defense Contract Management Agency
Funding agency: Department of Defense / U.S. Special Operations Command
Period of performance: 2018-11-29 to 2021-08-30
Current total value of award: $1975972
Description: SBIR PH II TOPIC&PROTOTYPE DEVELOPMENT USSOCOM 17.2 TOPIC 0002